Treatment and Evaluation Advances in Leprosy Neuropathy.
Ebenezer GJ, Scollard DM.
Neurotherapeutics. 2021 Oct;18(4):2337-2350. doi: 10.1007/s13311-021-01153-z. Epub 2021 Nov 19.
Leprosy neuropathy: clinical presentations.
Nascimento OJ.
Arq Neuropsiquiatr. 2013 Sep;71(9B):661-6. doi: 10.1590/0004-282X20130146.
Neurosurgical treatment of leprosy neuropathy in a low-incidence, European country.
Balestrino A, Fiaschi P, Riccardi N, Camera M, Anania P, Martinoli C, Gennaro S.
Neurol Sci. 2019 Jul;40(7):1371-1375. doi: 10.1007/s10072-019-03835-1. Epub 2019 Mar 22.
Leprous neuropathy.
Marques W.
Curr Opin Neurol. 2024 Oct 1;37(5):487-492. doi: 10.1097/WCO.0000000000001304. Epub 2024 Jul 25.
Pure neural leprosy or amyloid neuropathy? Systematic review and clinical case report.
Santos LOD, Fernandes TRMO, Barbosa TRS, Batista JADS, Souza CDF.
Rev Assoc Med Bras (1992). 2021 Jan;67(1):140-149. doi: 10.1590/1806-9282.67.01.20200422.
Peripheral neuropathy in leprosy and its consequences.
Van Brakel WH.
Lepr Rev. 2000 Dec;71 Suppl:S146-53. doi: 10.5935/0305-7518.20000086.
The armadillo as a model for peripheral neuropathy in leprosy.
Truman RW, Ebenezer GJ, Pena MT, Sharma R, Balamayooran G, Gillingwater TH, Scollard DM, McArthur JC, Rambukkana A.
ILAR J. 2014;54(3):304-14. doi: 10.1093/ilar/ilt050.
Kynurenines in the Pathogenesis of Peripheral Neuropathy During Leprosy and COVID-19.
de Oliveira JADP, de Athaide MM, Rahman AU, de Mattos Barbosa MG, Jardim MM, Moraes MO, Pinheiro RO.
Front Cell Infect Microbiol. 2022 Feb 24;12:815738. doi: 10.3389/fcimb.2022.815738. eCollection 2022.
Leprosy.
Walker SL, Lockwood DN.
Clin Dermatol. 2007 Mar-Apr;25(2):165-72. doi: 10.1016/j.clindermatol.2006.05.012.
Infectious neuropathy.
de Freitas MR.
Curr Opin Neurol. 2007 Oct;20(5):548-52. doi: 10.1097/WCO.0b013e32826fbca6.
